<- Go home

Added to YB: 2026-03-26

Pitch date: 2026-03-24

AZE.BR [neutral]

Azelis Group NV

+0.31%

current return

Author Info

Asymmetric Ventures Portfolio is a CFA and investor looking for asymmetric investments in Europe and North America. Sign up for the newsletter.

Company Info

Azelis Group NV engages in the distribution of specialty chemicals and food ingredients. The company provides specialty chemical products used in the life sciences, such as personal care, home care, industrial cleaning, pharmaceuticals, healthcare, food and nutrition, animal nutrition, agricultural environmental, flavours and fragrances, and nutraceuticals solutions; and industrial chemicals industry, including CASE, advanced materials and additives, lubricants, metalworking fluids, electronics, essential and fine chemicals, textiles, leather, and paper markets.

Market Cap

EUR 1.8B

Pitch Price

EUR 8.03

Price Target

N/A

Dividend

3.03%

EV/EBITDA

7.86

P/E

16.32

EV/Sales

0.84

Sector

Trading Companies and Distributors

Category

turnaround

Show full summary:
Azelis Group NV - $AZE.BR

AZE.BR (overview): #2 global specialty chems distributor, 63 countries, 4,206 employees serving 65K+ customers. Similar to IMCD but higher leverage (BB+ vs BBB-). EMEA ~50% EBITA. Asset-light model, <1% capex/rev. 3 yrs negative organic growth, margin compressed to 10%, net profit -40% to €113M, leverage 3.3x. Stock -71% since 2021 IPO. New CEO & CFO in 2024-26. EQT exited Feb'25 after 7 yrs

Read full article (7 min)